Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 57 Records) |
Query Trace: Breast Neoplasms and XRCC2[original query] |
---|
Screening of HELQ in breast and ovarian cancer families. Familial cancer 2015 Sep . Pelttari Liisa M, Kinnunen Laura, Kiiski Johanna I, Khan Sofia, Blomqvist Carl, Aittomäki Kristiina, Nevanlinna He |
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families. SpringerPlus 2015 4 92. Pelttari Liisa M, Kiiski Johanna I, Ranta Salla, Vilske Sara, Blomqvist Carl, Aittomäki Kristiina, Nevanlinna He |
Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women. Pathology oncology research : POR 2015 Sep 21 (4): 935-40. Michalska Magdalena M, Samulak Dariusz, Romanowicz Hanna, Smolarz Bea |
Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects. International journal of clinical and experimental medicine 0 8 (9): 15808-15814. Kong Bin, Lv Zhi-Dong, Chen Li, Shen Ruo-Wu, Jin Li-Ying, Yang Zhao-Chu |
MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Oct . Cao Jingjing, Luo Chenglin, Peng Rui, Guo Qiaoyun, Wang Kaijuan, Wang Peng, Ye Hua, Song Chunh |
Multigene testing of moderate-risk genes: be mindful of the missense. Journal of medical genetics 2016 06 53 (6): 366-76. Young E L, Feng B J, Stark A W, Damiola F, Durand G, Forey N, Francy T C, Gammon A, Kohlmann W K, Kaphingst K A, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette A M, Pertesi M, Robinot N, Rosenthal J S, Vallee M, Voegele C, Hopper J L, Southey M C, Andrulis I L, John E M, Hashibe M, Gertz J, , Le Calvez-Kelm F, Lesueur F, Goldgar D E, Tavtigian S |
Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks. Journal of medical genetics 2017 8 54 (11): 732-741. Decker Brennan, Allen Jamie, Luccarini Craig, Pooley Karen A, Shah Mitul, Bolla Manjeet K, Wang Qin, Ahmed Shahana, Baynes Caroline, Conroy Don M, Brown Judith, Luben Robert, Ostrander Elaine A, Pharoah Paul Dp, Dunning Alison M, Easton Douglas |
Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis. Asian Pacific journal of cancer prevention : APJCP 2017 07 18 (7): 1743-1749. Kamali Mahdieh, Hamadani Sedigheh, Neamatzadeh Hossein, Mazaheri Mahta, Zare Shehneh Masoud, Modaress Gilani Mitra, Haghighi Fatem |
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53. International journal of cancer 2017 08 141 (4): 750-756. Lolas Hamameh Suhair, Renbaum Paul, Kamal Lara, Dweik Dima, Salahat Mohammad, Jaraysa Tamara, Abu Rayyan Amal, Casadei Silvia, Mandell Jessica B, Gulsuner Suleyman, Lee Ming K, Walsh Tom, King Mary-Claire, Levy-Lahad Ephrat, Kanaan Moe |
Data on Single Nucleotide Polymorphism of DNA Repair Genes and Breast Cancer Risk from Poland. Pathology oncology research : POR 2017 12 25 (4): 1311-1317. Smolarz Beata, Bry? Magdalena, Forma Ewa, Zadro?ny Marek, Bie?kiewicz Jan, Romanowicz Han |
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers. European journal of human genetics : EJHG 2017 Dec 25 (12): 1345-1353. Golmard Lisa, Castéra Laurent, Krieger Sophie, Moncoutier Virginie, Abidallah Khadija, Tenreiro Henrique, Laugé Anthony, Tarabeux Julien, Millot Gael A, Nicolas André, Laé Marick, Abadie Caroline, Berthet Pascaline, Polycarpe Florence, Frébourg Thierry, Elan Camille, de Pauw Antoine, Gauthier-Villars Marion, Buecher Bruno, Stern Marc-Henri, Stoppa-Lyonnet Dominique, Vaur Dominique, Houdayer Clau |
Relative normalized luciferase activity for the recombinant vector constructs carrying the ancestral and variant alleles for XRCC2:rs3218550 and PHB:rs6917. BMC research notes 2018 9 11 (1): 643. Sirisena Nirmala Dushyanthi, Samaranayake Nilakshi, Dissanayake Vajira H |
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population. Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
Genetic determinants of sporadic breast cancer in Sri Lankan women. BMC cancer 2018 02 18 (1): 180. Sirisena Nirmala Dushyanthi, Adeyemo Adebowale, Kuruppu Anchala I, Neththikumara Nilaksha, Samaranayake Nilakshi, Dissanayake Vajira H |
Individual Genetic Variation Might Predict Acute Skin Reactions in Women Undergoing Adjuvant Breast Cancer Radiotherapy. Anticancer research 2018 Dec 38 (12): 6763-6770. Oliva Delmy, Nilsson Mats, Strandéus Michael, Andersson Bengt-Åke, Sharp Lena, Laytragoon-Lewin Nongnit, Lewin Fred |
Inherited variants in XRCC2 and the risk of breast cancer. Breast cancer research and treatment 2019 Aug . Klu?niak Wojciech, Woko?orczyk Dominika, Rusak Bogna, Huzarski Tomasz, Gronwald Jacek, Stempa Klaudia, Rudnicka Helena, Kashyap Aniruddh, D?bniak Tadeusz, Jakubowska Anna, Lener Marcin, Szwiec Marek, Tomiczek-Szwiec Joanna, Jarkiewicz-Tretyn Joanna, Cechowska Magdalena, Domaga?a Pawe?, Szymiczek Agata, Bagherzadeh Maryam, Lubi?ski Jan, Narod Steven A, Akbari Mohammad R, Cybulski Cezary, |
Electrophoretic mobility shift assays implicate XRCC2:rs3218550C>T as a potential low-penetrant susceptibility allele for sporadic breast cancer. BMC research notes 2019 8 12 (1): 476. Sirisena Nirmala D, Samaranayake Nilakshi, Dissanayake Vajira H |
New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients. Molecular biology reports 2019 7 46 (5): 5537-5541. Gervas Polina, Klyuch Boris, Denisov Evgeny, Kiselev Artem, Molokov Alexey, Pisareva Lubov, Malinovskaya Elena, Choynzonov Evgeny, Cherdyntseva Nadez |
The spectrum of mutations predisposing to familial breast cancer in Poland. International journal of cancer 2019 Jun . Cybulski Cezary, Klu?niak Wojciech, Huzarski Tomasz, Woko?orczyk Dominika, Kashyap Aniruddh, Rusak Bogna, Stempa Klaudia, Gronwald Jacek, Szymiczek Agata, Bagherzadeh Maryam, Jakubowska Anna, D?bniak Tadeusz, Lener Marcin, Rudnicka Helena, Szwiec Marek, Jarkiewicz-Tretyn Joanna, Stawicka Ma?gorzata, Domaga?a Pawe?, Narod Steven A, Lubi?ski Jan, Akbari Mohammad R, |
Polymorphism of DNA repair genes in breast cancer. Oncotarget 2019 Jan 10 (4): 527-535. Smolarz Beata, Michalska Magdalena M, Samulak Dariusz, Romanowicz Hanna, Wójcik Lui |
Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. Breast cancer research and treatment 2020 Jun . Alter Blanche P, Best Ana |
Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival. Cancers 2021 Jun 13 (12): . Li Wenjing, Amei Amei, Bui Francis, Norouzifar Saba, Lu Lingeng, Wang Zuohe |
Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin. Asian Pacific journal of cancer prevention : APJCP 2022 6 23 (6): 2027-2033. Gervas Polina, Molokov Aleksey, Babyshkina Nataliya, Kiselev Artem, Zarubin Aleksei, Yumov Evgeny, Pisareva Lubov, Choynzonov Evgeny, Cherdyntseva Nadez |
The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis. Cancer medicine 2022 Jun . Adolf Ismael C, Rweyemamu Linus P, Akan Gokce, Mselle Ted F, Dharsee Nazima, Namkinga Lucy A, Lyantagaye Sylvester L, Atalar Fatmah |
Homologous recombination DNA repair gene RAD51, XRCC2 & XRCC3 polymorphisms and breast cancer risk in South Indian women. PloS one 0 17 (1): e0259761. Rajagopal Taruna, Seshachalam Arun, Rathnam Krishna Kumar, Talluri Srikanth, Venkatabalasubramanian Sivaramakrishnan, Dunna Nageswara R |
Comprehensive Analysis of the Expression and Prognosis for RAD51 Family in Human Breast Cancer. International journal of general medicine 2022 15 4925-4936. Shi Yaqin, Shen Meng, Xu Mengdan, Tao Min, Chen Kai, Zhu Qingqi |
Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study. Asian Pacific journal of cancer prevention : APJCP 2023 9 24 (9): 3065-3075. Kailas D Datkhile, Rashmi A Gudur, Suresh J Bhosale, Pratik P Durgawale, Nilam J Jagdale, Ashwini L More, Anand K Gudur, Satish R Pat |
Association of RAD51, XRCC1, XRCC2, and XRCC3 Polymorphisms with Risk of Breast Cancer. Genetic testing and molecular biomarkers 2023 7 27 (7): 205-214. Priyanka Gupta, Vasudha Sambyal, Kamlesh Guleria, Manjit Singh Uppal, Meena Sud |
Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T?XRCC2 & XRCC3 and risk of breast cancer: A meta-analysis. Frontiers in oncology 2023 2 13 1047336. Yu Jiayang, Wang Chun-Gua |
Association between XRCC2 Arg188His Polymorphism and Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis. Asian Pacific journal of cancer prevention : APJCP 2024 1 25 (1): 43-55. Seyed Alireza Dastgheib, Soheila Sayad, Sepideh Azizi, Nazanin Hajizadeh, Fatemeh Asadian, Mojgan Karimi-Zarchi, Maedeh Barahman, Amirmaoud Shiri, Mohammad Manzourolhojeh, Kazem Aghili, Hossein Neamatzad |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: